Flexmore PM
- Product NDC
- 54973-3401
- Requested package NDC
- 54973-3401-2
- 11-digit product format
- 549733401
- Labeler code
- 54973
- Product ID
- 54973-3401_efa4f263-df82-446e-e053-2a95a90a5194
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- BRYONIA ALBA ROOT,ERROSOFERRIC PHOSPHATE,RHODODENDRON TOMENTOSUM LEAFY TWIG,COLCHICUM AUTUMNALE BULB,ANEMONE PULSATILLA,POTASSIUM PHOSPHATE, DIBASIC,KALMIA LATIFOLIA LEAF,COMFREY ROOT,TOXICODENDRON PUBESCENS LEAF and ATROPA BELLADONNA
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Hyland's Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2019-06-01
- Marketing end
- 0000-00-00
- Substance
- ANEMONE PULSATILLA; ATROPA BELLADONNA; BRYONIA ALBA ROOT; COLCHICUM AUTUMNALE BULB; COMFREY ROOT; FERROSOFERRIC PHOSPHATE; KALMIA LATIFOLIA LEAF; POTASSIUM PHOSPHATE, DIBASIC; RHODODENDRON TOMENTOSUM LEAFY TWIG; TOXICODENDRON PUBESCENS LEAF
- Active strength
- 12 [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 54973-3401 | 54973-3401-2 | D | Discontinued by firm | 2026-10-05 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54973-3401-2 | 54973340102 | 4 TABLET in 1 PACKET (54973-3401-2) | 4 tablet | 2019-06-01 | 0000-00-00 | No | No | Current |